Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy

BACKGROUND: Pharmacokinetic interactions between rifampicin and protease inhibitors (PIs) complicate the management of HIV-associated tuberculosis. Rifabutin is an alternative rifamycin, for patients requiring PIs. Recently some international guidelines have recommended a higher dose of rifabutin (1...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Pharmacol Toxicol
Main Authors: Naiker, Suhashni, Connolly, Cathy, Wiesner, Lubbe, Kellerman, Tracey, Reddy, Tarylee, Harries, Anthony, McIlleron, Helen, Lienhardt, Christian, Pym, Alexander
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4277828/
https://ncbi.nlm.nih.gov/pubmed/25406657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-6511-15-61
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki